- Home
- TKLF vs TRIB Comparison
TKLF vs TRIB Comparison
Compare TKLF & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TKLF
- TRIB
- Stock Information
- Founded
- TKLF 2006
- TRIB 1992
- Country
- TKLF Japan
- TRIB Ireland
- Employees
- TKLF N/A
- TRIB N/A
- Industry
- TKLF Other Specialty Stores
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- TKLF Consumer Discretionary
- TRIB Health Care
- Exchange
- TKLF Nasdaq
- TRIB Nasdaq
- Market Cap
- TKLF 13.3M
- TRIB 10.7M
- IPO Year
- TKLF 2022
- TRIB N/A
- Fundamental
- Price
- TKLF $4.03
- TRIB $0.80
- Analyst Decision
- TKLF
- TRIB
- Analyst Count
- TKLF 0
- TRIB 0
- Target Price
- TKLF N/A
- TRIB N/A
- AVG Volume (30 Days)
- TKLF 42.3K
- TRIB 71.2K
- Earning Date
- TKLF 12-18-2024
- TRIB 05-27-2025
- Dividend Yield
- TKLF N/A
- TRIB N/A
- EPS Growth
- TKLF N/A
- TRIB N/A
- EPS
- TKLF 1.70
- TRIB N/A
- Revenue
- TKLF $219,520,631.00
- TRIB $59,126,000.00
- Revenue This Year
- TKLF N/A
- TRIB $11.63
- Revenue Next Year
- TKLF N/A
- TRIB $10.13
- P/E Ratio
- TKLF $2.37
- TRIB N/A
- Revenue Growth
- TKLF 32.02
- TRIB N/A
- 52 Week Low
- TKLF $2.00
- TRIB $0.48
- 52 Week High
- TKLF $8.53
- TRIB $3.55
- Technical
- Relative Strength Index (RSI)
- TKLF 76.81
- TRIB 61.50
- Support Level
- TKLF $3.71
- TRIB $0.71
- Resistance Level
- TKLF $3.90
- TRIB $0.84
- Average True Range (ATR)
- TKLF 0.30
- TRIB 0.07
- MACD
- TKLF 0.07
- TRIB 0.00
- Stochastic Oscillator
- TKLF 88.05
- TRIB 68.00
About TKLF Yoshitsu Co. Ltd
Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores; Online Stores and Services; and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from China followed by Japan and other overseas markets.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.